Stephen M Storm

Title: The Innovative Contributions of Stephen M Storm

Introduction

Stephen M Storm is a notable inventor based in Richboro, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of liver toxicity. His work focuses on identifying biomarkers that can predict hepatotoxicity, which is crucial for the safety of various therapeutic agents.

Latest Patents

Stephen M Storm holds a patent for the "Identification of biomarkers for liver toxicity." This invention relates to biomarker polypeptides, polynucleotides, and antibodies that are useful in predicting in vitro and/or in vivo hepatotoxicity of various drugs and compounds. The patent also encompasses screens, kits, microarrays, and cell culture systems that utilize these biomolecules. The methods and reagents developed through this patent can help identify substances that may cause liver injury, thereby preventing serious medical complications such as liver failure.

Career Highlights

Stephen M Storm is associated with Bristol-Myers Squibb Company, where he applies his expertise in drug safety and biomarker research. His work is instrumental in advancing the understanding of drug-induced liver toxicity, which is a critical aspect of pharmaceutical development.

Collaborations

Stephen has collaborated with notable colleagues, including Frederic Moulin and Donna Dambach. These collaborations have further enhanced the research and development of innovative solutions in the field of hepatotoxicity.

Conclusion

Stephen M Storm's contributions to the identification of liver toxicity biomarkers represent a significant advancement in drug safety. His work not only aids in the development of safer therapeutic agents but also plays a vital role in preventing potential medical complications.